On the third episode of its “Digital First Scientific Communications” series, the Patients Rising Podcast looks into how article-level metrics are changing the landscape of medical publications. Co-moderators Jennifer Riggins, PharmD, and Steve Casey Interview Jennifer Ghith, Innovations Director of […]
Virus Strongly Linked to Multiple Sclerosis in New Study
Infection with the Epstein-Barr virus dramatically raised the risk of developing multiple sclerosis (MS), according to a newly-published paper in Science. People infected with the virus, which causes mononucleosis, had a 32-fold higher chance of developing MS. Samples were pulled from the Department […]
Higher Risk of COVID-19 complications and Newborn Deaths for Unvaccinated Pregnant People
Nearly every pregnant person in critical care for COVID-19 was unvaccinated, according to a recently published population-level study from Scotland. The paper, published in Nature Medicine, looked at data from Scotland taken between December 2020 and October 2021 on all pregnant people in the […]
Aduhelm Sparks Discourse about Equity in Alzheimer’s Care
The debate over systemic inequity in Alzheimer’s treatment has been stirred once again by Medicare’s proposal to only cover Aduhelm, Biogen’s controversial Alzheimer’s drug, for patients enrolled in clinical trials. Black and Hispanic people face higher rates of Alzheimer’s disease, but are starkly […]
Managed Healthcare Executive Releases 2022 State of the Industry Survey
Respondents expressed middling optimism towards improvements to the American healthcare industry in 2022, according to Managed Healthcare Executive’s 2022 State of the Industry Survey. The survey, which polled 100 respondents about various topics regarding the upcoming year, was just released in […]
On Medicare Limiting Coverage for Alzheimer’s Drug
Biogen’s outrageous original price for Aduhelm, $56,000 per year, is the poster child for how dysfunctional our drug pricing system has become and it is the perfect example of why Medicare should be negotiating drug prices with the pharmaceutical industry. If the administration takes no action, […]
Health care: ‘We will see more and more specialty drugs,’ Cigna CEO says
Cigna CEO David Cordani joined Yahoo Finance’s Anjalee Khemlani to discuss access to health care, innovation in therapeutics, and drug affordability. Video Transcript ALEXIS CHRISTOFOROUS: Lowering the cost of prescription drugs has been a hotly debated topic for years, and it's certainly not going […]
Medicare to limit coverage of contentious Alzheimer’s drug – Politico
With help from Megan R. Wilson and Katherine Ellen Foley Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our subscribers each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take […]
McDermott 2022 Health Policy Outlook
McDermott 2022 Health Policy Outlook As we start a new year and new congressional session, we are taking a look at the health policy priorities that are likely to dominate the agenda in 2022. Following is our top 10 list (plus a few more) of health policy topics to watch. Read the source […]
ISPOR Webinar: The Future of Biosimilars
Biosimilars are poised to increase access to otherwise expensive therapies, but legal and regulatory hurdles abound. In an ISPOR webinar taking place on January 19th, 2022, presenters Aurelio Arias, MSc, Cate Lockhart, MS, PharmD, PhD, and Emma Foreman, BS will speak with moderator Liese Barbier […]
Year in Review: Real-world Evidence in 2021
The Evidence Base rang in the new year with a look back at the real-world evidence (RWE) landscape of 2021. In this retrospective, Darcy Hodge highlights the FDA’s push for clear RWE standards in clinical trials and approval applications. In addition, she examines how the rise of RWE in 2021 was […]
Healthcare Consulting Services Market by Type of Service (Digital Health, IT, Operations, Strategy, Financial, Hr & Talent), End User (Government Bodies, Healthcare Providers, Pharmaceutical & Biotechnology Companies), and Region – Global Forecasts to 2
Global healthcare consulting services market is projected to grow at CAGR of 11.5%” The global healthcare consulting services market is projected to reach USD 41.2 billion by 2026 from USD 23.9 billion in 2021, at a CAGR of 11.5% during the forecast period. Read the source article at Sandler […]
EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines Seite 1 – 10.01.2022
The two companies will explore opportunities for a long-term, strategic partnership spanning the CVS Health enterprise Includes CVS Caremark, the leading pharmacy benefit manager in the U.S., covering 1 in 3 Americans – nearly 110 million lives Initial focus will be on EQRx’s two lead oncology […]
Roche introduces cobas infinity edge, a new open digital ecosystem for point of care professionals, driving improved patient outcomes and operational efficiencies in healthcare
Roche’s new cloud-based platform connects patient test results, medical records and third-party applications, allowing professionals to monitor patients’ health, adjust treatment protocols, and make quick data-driven patient care decisions anytime, anywhere within and across clinical settings. […]
Sarah Evanega pioneers visionary grassroots model for science communication
On Jan. 7, Sarah Evanega stepped down as director of the Alliance for Science to assume a new position at Pairwise , a gene editing start-up. In the eight years since she founded the Alliance, Evanega has mobilized and led an international coalition of communicators who advocate for science-based […]
RWE in Pharma Interview Series: Clare Hague
Clare Hague, EMEA Therapeutic Area Market Access Leader at Janssen, was featured in The Evidence Base’s RWE in Pharma series last year. Hague laid out the growing role of real-world data and evidence (RWD, RWE) in the pharmaceutical industry, especially in the field of rare diseases. She also […]
Pharmacy Outlook: Sheila Arquette, NASP
Specialty pharmacies support patients diagnosed with life-altering and oftentimes life threatening complex health conditions, including cancer, rheumatoid arthritis, multiple sclerosis, cystic fibrosis, hemophilia, rare and orphan diseases and organ transplantation. The National Association of […]
Medifakt, unleashing Blockchain’s potential for the healthcare industry
It is an enterprise-grade blockchain platform tailored to the healthcare sector’s regulatory, operational, and market needs TALLINN, ESTONIA, January 9, 2022 / EINPresswire.com / — Medifakt, an enterprise-level Decentralized Healthcare Ecosystem, uses a combination of Blockchain, the Internet of […]
Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene Therapy Programs and Outlines Key 2022 Milestones
Launch Momentum Building for Libmeldy ® in Europe with Health Technology Assessments Progressing Favorably and Treatment Underway for Multiple Commercial Patients Initiating U.S. BLA Submission for OTL-200 as Early as Year End 2022; Constructive CMC Meeting with FDA Supports Timeline EU MAA […]
Case Study: MMIT’s Analytics Platform Saves Time and Resources for Healthcare Services Company
MMIT has released a case report detailing how its MMIT Analytics platform helped one healthcare services company save time and resources when communicating with providers. Their platform allowed them to change course from asking providers to contact payers for patient coverage […]
Opinion: Build Back Better would set back medical science
Xavier Becerra testifies during a Senate Finance Committee hearing on his nomination to be secretary of Health and Human Services last year. File photo Democrats are hoping to include a major overhaul of Medicare prescription drug pricing in their Build Back Better legislation. The proposal would […]
STAT Health Tech: Healthcare Mergers and Acquisitions on the Rise
Several healthcare and biotech mergers and acquisitions (M&A) have been announced in recent months, according to the latest STAT Health Tech newsletter by STAT News. In the newsletter, authors Casey Ross and Katie Palmer discuss Withings’ acquisition of Impeto Health, Speak2Family’s acquisition […]
IBM Makes Another Attempt to Sell Watson Health
IBM is once again trying to sell IBM Watson Health with aims to make more than $1 billion. This comes after a first attempt to sell the division in late 2021 due to them deeming it unprofitable. Bids were closed as of January 4th, and the winner will likely be announced later this month. Alongside […]
Draft Ruling from CMS Suggests Narrow Coverage for Aduhelm
The Centers for Medicare & Medicaid Services (CMS) have released a draft ruling indicating it will only cover Biogen’s Alzheimer’s drug Aduhelm for patients in clinical trials. This ruling will have a stark financial impact on Biogen if it becomes final guidance, as older individuals, the […]
Upcoming Webinar: Getting Real with Real-World Evidence
Fierce Pharma and Databricks are hosting a webinar at 12 pm ET / 9 am PT, on Thursday, January 27th, 2022. The webinar will focus on the challenges surrounding real-world evidence (RWE) in the biopharma industry. In addition, ways in which RWE can be leveraged to open new opportunities will be […]
2022 Dealmakers’ Intentions Survey Released
Syneos Health Consulting has released the results of its 2022 Dealmakers’ Intentions Survey. The survey’s finding indicated that IPO markets and venture financing will benefit small companies over the upcoming year. The report predicts that the access to extra capital will allow smaller firms to […]
Amgen and Arrakis Therapeutics Announce Partnership to Develop RNA-targeting Oral Drugs
The biotech startup Arrakis Therapeutics has partnered with Amgen in a research collaboration to develop oral drugs that target disease-related RNA. Arrakis will be payed $75 million for five initial drug discovery options, with billions of dollars on the table if the programs are successful. Amgen […]
Pfizer Shifts to Virtual Meetings and Cuts Sales Staff
Pfizer will lay off sales staff as they pivot towards virtual sales meetings with providers to adjust to changing provider preferences. The company, which is expected to report 2021 revenue of over $80 billion, has not announced the amount of employees they will be laying off later this […]
Market Access Speed Makes the Differences for Pharma
Advances in science and legislative changes have accelerated drug discovery and approval in recent years. However, payers eye these drugs with increased skepticism due to ballooning healthcare costs. Therefore, pharma companies must consider market access and commercialization earlier in the […]
Pfizer, GSK and Teva lead 2022’s round of January drug price hikes: GoodRx
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx fkansteiner Tue, 01/04/2022 - 11:30 Read the source article at Pharma News 2022-01-04 16:13:23 […]
